Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: United Kingdom Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20054
20065
20072
20082
20105
20111
20123
20138
20141
20152
20162
20172
20181
20201
20214
20223
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting6
Terminated5
Active, not recruiting3
Unknown status3
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals21
Bristol-Myers Squibb7
Pfizer5
Ariad Pharmaceuticals2
European Society for Blood and Marrow Transplantation2
Imperial College London2
Teva Branded Pharmaceutical Products R&D, Inc.2
Agenus Inc.1
Ascentage Pharma Group Inc.1
Cell Medica Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive57
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia10
Leukemia, Myeloid, Chronic-Phase10
Leukemia, Myeloid, Acute7
Philadelphia Chromosome6
Bone Marrow Diseases5
Hematologic Diseases5
Leukemia, Myeloid5
Myeloproliferative Disorders5

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.